婚姻状况对眼癌患者的诊断和生存的影响:一项观察性研究
Yu Zhou1, Yi Feng1, Min Zhang2
1Department of Ophthalmology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, China.
Medicine
|September 3, 2025
概括
与已婚患者相比,未婚患者的眼睛癌症诊断晚期, 幸存率更差. 在这一群体中,婚姻似乎是更好的整体存活率和癌症特定存活率的独立预测因素.
科学领域:
- 眼科 眼科
- 癌症学
- 社会科学
背景情况:
- 婚姻状况通过情感支持,决策和医疗保健获得影响癌症管理.
- 婚姻状况对眼癌诊断和生存率的影响尚不清楚.
研究的目的:
- 调查婚姻状况与眼部癌症的诊断阶段之间的联系.
- 评估婚姻状况对眼癌患者的整体存活率 (OS) 和癌症特异性存活率 (CSS) 的影响.
主要方法:
- 使用了来自监测,流行病学和最终结果 (SEER) 数据库 (2000-2019) 的数据.
- 使用多变量顺序逻辑回归来进行诊断阶段分析.
- 应用倾向分数匹配和卡普兰-梅尔曲线来评估生存结果.
主要成果:
- 没有结婚的患者更有可能被诊断为晚期眼癌 (OR=1. 31,P=. 001).
- 在匹配后,未婚患者的生存状况明显恶化 (HR=1. 40,P<. 001) 和CSS (HR=1.13,P=. 022).
- 随着时间的推移,生存差异扩大,女性,老年人和低风险群体更明显.
结论:
- 在眼癌患者中,未婚状态是较差的生存状况和CSS的独立预测因素.
- 婚姻与眼睛癌症的生存率有所改善,特别是在特定的人口群体中.
- 这些发现强调了在眼部癌症治疗和支持策略中考虑婚姻状况的重要性.
相关概念视频
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Comparing the Survival Analysis of Two or More Groups
280
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
280
Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


